UnknownNot Applicable

Evaluation of the Efficacy of Intralesional Injection of Combined Digoxin and Furosemide Versus 5 - Fluorouracil in Treatment of Plantar Warts

Egypt60 participantsStarted 2022-07-01

Plain-language summary

Warts are common skin infections caused by human papillomavirus (HPV), which can cause a variety of skin presentations according to its type, site and the immune status .Nongenital warts may be presented as common, plane, plantar, filiform, or mucosal warts .Most people are affected by cutaneous warts, either plantar warts or common warts .prevalence of skin warts is between 3% and 13% and plantar warts are about 30% of skin warts in western world .Majority of cases occur in adolescent and young adults

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age:\>18 years . * Sex: both males and females will be included. * Confirmed diagnosis by clinical and dermoscopic examination of plantar warts will be made Exclusion Criteria: * Patients with history or evidenced hypersensitivity to any component used in this study. * Pregnancy \& lactating. * Patients who receive immune suppressive therapy. * Patients who receive any wart treatment during the last 2 months before enrollment in the study. * Patients with systemic illness especially cardiac patients. * Patients who refused participation in the study

What they're measuring

the change in size of plantar wart

Timeframe: 3 month

the change in number of plantar warts

Timeframe: 3 month

Trial details

NCT IDNCT05520658

SponsorSohag University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-09

Contact for this trial

samah R Ahmed, resident

01128636414 samah_ragab_post@med.sohag.edu.eg

View on ClinicalTrials.gov More Plantar Wart trials